Korro Bio (KRRO) Net Cash Flow Growth (3y) (2021 - 2026)
Korro Bio (KRRO) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -1.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06% |
| Dec 31, 2025 | 29.19% |
| Sep 30, 2025 | -103.43% |
| Jun 30, 2025 | -59.96% |
| Mar 31, 2025 | 31.72% |
| Dec 31, 2024 | 33.99% |
| Sep 30, 2024 | -6.57% |
| Jun 30, 2024 | -13.06% |
| Mar 31, 2024 | 18.80% |
| Dec 31, 2023 | 221.91% |
| Sep 30, 2023 | -34.95% |
| Jun 30, 2023 | -33.11% |
| Mar 31, 2023 | 107.16% |
| Dec 31, 2022 | -28.40% |
| Sep 30, 2022 | -78.01% |
| Jun 30, 2022 | -69.11% |
| Mar 31, 2022 | 10.19% |
| Dec 31, 2021 | -45.56% |